ABUS logo

ABUS
Arbutus Biopharma Corp

16,745
Mkt Cap
$916.57M
Volume
3.67M
52W High
$5.10
52W Low
$3.04
PE Ratio
5.64
ABUS Fundamentals
Price
$4.64
Prev Close
$4.64
Open
$4.69
50D MA
$4.37
Beta
0.93
Avg. Volume
2.06M
EPS (Annual)
-$0.1748
P/B
3.51
Rev/Employee
$741,210.53
$834.31
Loading...
Loading...

About

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
19

Frequently Asked Questions

What is Market Cap of Arbutus Biopharma Corp?
What is the 52-week high for Arbutus Biopharma Corp?
What is the 52-week low for Arbutus Biopharma Corp?
What is Arbutus Biopharma Corp stock price today?
What was Arbutus Biopharma Corp stock price yesterday?
What is the PE ratio of Arbutus Biopharma Corp?
What is the Price-to-Book ratio of Arbutus Biopharma Corp?
What is the 50-day moving average of Arbutus Biopharma Corp?
How many employees does Arbutus Biopharma Corp have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available